In contrast, a number of recent investigations, as detailed in the introduction, have shown the opposite, suggesting that bile acids might exert anti-tumour effects in solid cancers (26), but these effects are strictly dependent on their concentrations, cellular microenvironment and expression of key receptors such as FXR and GPBAR1 (30). Here, GPBAR1 is linked to neoplasm.